At least 10 experimental coronavirus vaccines are in human testing, mostly smaller Phase 1 studies designed to give preliminary evidence of safety and to help select a dose for larger trials. Three of those vaccines, from the University of Oxford, the U.S. biotech Moderna and China’s CanSino Biologics, have already progressed through initial study phases and…

Our next post in the Biotechnology: Beyond Imagination series highlights MaxCyte and the cell therapy technology the company has developed for researchers to accelerate, streamline and improve the drug development process. Beyond Imagination Member Spotlight: MaxCyte About half of the 300 million people who live with a rare disease, like autoimmune disorders and cancers, do not have…

The global Covid-19 pandemic has left families and communities around the globe grieving for lost loved ones, exhausted from prolonged social isolation, and anxious about their financial future as unemployment reaches levels not seen since the Great Depression. But it is also driving an unprecedented transformation of the global medical research ecosystem through the search for effective new…

As if we all needed another health concern, Lyme disease season has arrived. A walk in the woods might be an appealing way to relieve stress from the coronavirus lockdown, but it comes with an underappreciated risk: Ticks that carry Lyme and other illnesses. Some of the basic symptoms of a Lyme infection — fever,…

Late last month, MedTech Innovator in partnership with BARDA held an online event to hear pitches from start-up companies developing technologies related to the ongoing coronavirus pandemic.  MedTech Innovator matches healthcare industry leaders with innovative early-stage and emerging growth medtech companies for mentorship and support. Here is the list of 16 companies that have technologies set…

While aiming to double its manufacturing capacity to more than 50 million blood tests per month, Siemens Healthineers has begun shipping its COVID-19 serology kits internationally, for use on about 20,000 analyzer systems installed worldwide. The company recently received a CE mark for its IgM and IgG antibody test, designed to run on its high-throughput…

Hundreds of teams are competing a la ‘Shark Tank’ for NIH funding to develop at-home diagnostic strips and other options Even as coronavirus testing ramps up around the country, businesses and public-health authorities seeking to safely reopen are hitting a speed-bump: Standard testing techniques still require sophisticated lab equipment and can take hours or even…

Merck, one of the largest vaccine makers in the world, is entering the Covid-19 arena with an announcement on Tuesday it is developing two different vaccines for Covid-19 and is also licensing an oral drug that might treat the virus. Merck is buying Vienna-based Themis, which is developing an experimental Covid-19 vaccine based on a measles…

Clinicians and regulators are rethinking how healthcare is provided amid precautions prompted by COVID-19. In-person physician visits don’t fit within the physical distancing guidelines that are now the new normal. New technology presents alternatives. As a digital therapeutics startup, Akili Interactive finds itself thrust in the midst of these changes. The Boston company has developed…